TradingView
Libratus
Sep 21, 2020 6:15 AM
CRSP- Pioneer and leader in gene editing
NASDAQ:CRSP
1D
CRISPR Therapeutics AG
NASDAQ
Description
⋅
Sep 21, 2020 6:15 AM
CRSP is the leader and pioneer of the CRISPR/CAS9 gene-editing breakthrough. It is a long-term bet as short-term to mid-term future is uncertain.
I think it has one more leg down. Accumulate in the demand zone.
Trend Analysis
Technical Indicators
Fundamental Analysis
CRSP
crspr
geneediting
EDIT
NTLA
beam
More